Stay tuned for the 2021 edition!


Sara Tylosky, CEO, Farmacon

Sara Tylosky, CEO of Farmacon, has over 20 experience in strategic management, clinical research and market access in the pharmaceutical & biotech industries, in the US, Latin America and globally. She worked previously in big and small Pharma, including GSK and MedPointe, and started Farmacon 11 years ago to help navigate clinical research and market challenges in Latin America. Sara holds a Masters in Business from Florida Atlantic University, and an undergraduate degree from Whitman College.